Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.

First clinical trial of innovative new ICR-discovered drug begins

The first patients are set to receive a new drug, targeting the HSF1 pathway, as part of a clinical trial.
New trial launches
What could the next decade bring?

The research areas that could revolutionise prostate cancer treatment in years to come.
Looking to the future
Help us make more discoveries to defeat prostate cancer

Advances in our research are helping men live longer and with a better quality of life. With your support, we will continue to find new ways to defeat prostate cancer – so more men will survive this disease.
Prostate cancer appeal

1/3

Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours.
About drug discovery
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Big data research
Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Our innovative approaches
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Personalised treatments
Making it count

We will deliver better outcomes and quality of life for patients by establishing innovative treatments, diagnostics and prevention strategies as part of routine healthcare.
Improving patient lives
Queen's Anniversary Prize

The ICR has been recognised with a prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Queen's Anniversary Prize